Loading company…
NeoCura develops RNA-based drug candidates and platforms focused on tumors and vaccines.
Founded in 2017 and based in Shenzhen, China, NeoCura uses RNA technology and AI-based drug discovery tools to develop treatments focused on tumors and viral diseases. Its pipeline includes tumor neoantigen vaccines, tumor microenvironment immunomodulation and virus vaccines. The company also has offices in Beijing and Guangzhou.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in